Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04125810Phase 2Completed

A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress

Role: collaborator

NCT04229082Completed

Next Generation Probiotics (NGPs) for Metabolic Health

Role: collaborator

NCT03569202Not ApplicableCompleted

Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye

Role: collaborator

NCT01690676Phase 2Completed

Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function

Role: collaborator

All 4 trials loaded